<DOC>
	<DOCNO>NCT02477033</DOCNO>
	<brief_summary>During project safety , tolerability effect gut microbiota oral administration Butyricicoccus pullicaecorum investigate healthy human volunteer placebo-controlled cross-over randomize study .</brief_summary>
	<brief_title>Impact Butyricicoccus Pullicaecorum Healthy Subjects</brief_title>
	<detailed_description>Intervention period 4 week , daily intake 1 capsule . Wash-out period 3 week .</detailed_description>
	<criteria>BMI 18 28 kg/mÂ² Good general health Regular eating pattern ( 3 meals/day least 5 days/week ) Chronic gastrointestinal disease ( Crohn 's disease , ulcerative colitis , irritable bowel syndrome , chronic constipation chronic diarrhea ) Surgery gastrointestinal tract ( except appendectomy ) Use antibiotic month precede study Use medication dietary supplement influence gut transit intestinal microbiota month precede study . Examples medication/dietary supplement antispasmodic ( e.g . buscopan ) , antidiarrheal medication ( e.g . imodium ) , probiotic medication ( e.g . lacteol , enterol ) Intake pre probiotic study month precede study Being weightloss diet study month precede study Extreme dietary habit ( e.g . vegan , Atkins diet , Montignac diet ) Females pregnant , lactate plan become pregnant study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>